Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, today announced that the company and Rapid Response Defense Systems…
PaxMedica (NASDAQ: PXMD), a biopharmaceutical company focused on advancing treatments for neurological disorders, has closed its previously announced public offering.…
In August 2023, SOHM signed an LOI with CGA Intellectual Holdings Inc. to acquire disruptive stem cell technology and patents…
D-Wave third-quarter revenue grew by 51% year-over-year D-Wave’s third quarter bookings increased by 53% year-over-year, representing the company’s sixth consecutive…
MedCana announced in May 2023 full-scale production of non-THC cannabis for export to Europe The company earlier in 2023 commenced…
Renovaro BioSciences (NASDAQ: RENB) (formerly NASDAQ: ENOB), an advanced, preclinical biotechnology firm in cell, gene and immunotherapy focused on solid tumors with short…
Safety Shot (NASDAQ: SHOT) today announced that it has come to its attention that there are several disclosed short sellers…
Electronic Servitor Publication Network (OTC: XESP), focused on disrupting the market for B2B companies by driving better digital interactions and…
CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in…
Genprex was granted orphan drug designation by the FDA earlier this year for development of REQORSA combined with Tecentriq in…